As of September 2024, Immuno-Biological Laboratories has a market cap of $29.54M. This makes Immuno-Biological Laboratories the world's 28002th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $31.31M | -3.04% |
2023 | $32.29M | 64.33% |
2022 | $19.65M | -11.76% |
2021 | $22.27M | -34.24% |
2020 | $33.86M | -24.42% |
2019 | $44.80M | 14.77% |
2018 | $39.04M | -21.16% |
2017 | $49.51M | -6.44% |
2016 | $52.92M | -21.02% |
2015 | $67.00M | -2.01% |
2014 | $68.38M | -22.15% |
2013 | $87.83M | 172.28% |
2012 | $32.26M | 10.80% |
2011 | $29.11M | 326.17% |
2010 | $6.83M | -14.51% |
2009 | $7.99M | 46.99% |
2008 | $5.44M | -81.80% |
2007 | $29.87M | - |